Replies to post #208544 on Biotech Values

[DewDiligence]

OCRX—Did they say anything on the oral program?

Insofar as the STOP-HE results imply that dosing should be higher, OCRX will have to reexamine the dosing for the oral formulation. Other than that, there are no changes planned for the oral program at this time.